CryptoMedix

CryptoMedix LLC is a biotechnology company that engages in the discovery, clinical development, and commercialization of a portfolio.

CryptoMedix LLC is a biotechnology company that engages in the discovery, clinical development, and commercialization of a portfolio of therapeutic biologics and diagnostic agents for cancer and certain inflammatory diseases. It focuses on a set of core monoclonal antibodies (mAbs) at various stages of pre-clinical and early clinical development that specifically target and inhibit distinct ‘cryptic’ epitopes of collagen. The company was founded in 2013 and is based in Harpswell, Maine.